Alkem Laboratories Statistics

Total Valuation

Alkem Laboratories has a market cap or net worth of INR 646.40 billion. The enterprise value is 642.47 billion.

Market Cap	646.40B
Enterprise Value	642.47B

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	Aug 9, 2024

Share Statistics

Alkem Laboratories has 119.57 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	119.57M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	42.43%
Owned by Institutions (%)	24.68%
Float	42.00M

Valuation Ratios

The trailing PE ratio is 30.46 and the forward PE ratio is 27.29. Alkem Laboratories's PEG ratio is 2.90.

PE Ratio	30.46
Forward PE	27.29
PS Ratio	5.04
PB Ratio	5.62
P/TBV Ratio	5.90
P/FCF Ratio	42.94
P/OCF Ratio	n/a
PEG Ratio	2.90

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.66, with an EV/FCF ratio of 42.68.

EV / Earnings	30.27
EV / Sales	5.01
EV / EBITDA	24.66
EV / EBIT	27.86
EV / FCF	42.68

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.12.

Current Ratio	2.66
Quick Ratio	1.15
Debt / Equity	0.12
Debt / EBITDA	0.57
Debt / FCF	0.98
Interest Coverage	29.74

Financial Efficiency

Return on equity (ROE) is 19.53% and return on invested capital (ROIC) is 11.50%.

Return on Equity (ROE)	19.53%
Return on Assets (ROA)	8.99%
Return on Capital (ROIC)	11.50%
Revenue Per Employee	7.36M
Profits Per Employee	1.22M
Employee Count	17,432
Asset Turnover	0.80
Inventory Turnover	1.77

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +10.01% in the last 52 weeks. The beta is 0.40, so Alkem Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+10.01%
50-Day Moving Average	5,687.89
200-Day Moving Average	5,443.99
Relative Strength Index (RSI)	41.52
Average Volume (20 Days)	137,770

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Alkem Laboratories had revenue of INR 128.32 billion and earned 21.22 billion in profits. Earnings per share was 177.51.

Revenue	128.32B
Gross Profit	80.13B
Operating Income	23.06B
Pretax Income	24.22B
Net Income	21.22B
EBITDA	25.78B
EBIT	23.06B
Earnings Per Share (EPS)	177.51

Full Income Statement

Balance Sheet

The company has 22.89 billion in cash and 14.78 billion in debt, giving a net cash position of 8.11 billion or 67.83 per share.

Cash & Cash Equivalents	22.89B
Total Debt	14.78B
Net Cash	8.11B
Net Cash Per Share	67.83
Equity (Book Value)	119.10B
Book Value Per Share	961.30
Working Capital	69.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.55 billion and capital expenditures -4.50 billion, giving a free cash flow of 15.05 billion.

Operating Cash Flow	19.55B
Capital Expenditures	-4.50B
Free Cash Flow	15.05B
FCF Per Share	125.91

Full Cash Flow Statement

Margins

Gross margin is 62.44%, with operating and profit margins of 17.97% and 16.54%.

Gross Margin	62.44%
Operating Margin	17.97%
Pretax Margin	18.87%
Profit Margin	16.54%
EBITDA Margin	20.09%
EBIT Margin	17.97%
FCF Margin	11.73%

Dividends & Yields

This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 0.74%.

Dividend Per Share	40.00
Dividend Yield	0.74%
Dividend Growth (YoY)	-20.00%
Years of Dividend Growth	6
Payout Ratio	22.53%
Buyback Yield	0.01%
Shareholder Yield	0.75%
Earnings Yield	3.28%
FCF Yield	2.33%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a